BIOMARKERS FOR TREATING CANCER WITH APILIMOD

The present disclosure relates to compositions and methods for treating cancer in a subject having cancer cells overexpressing a microphthalmia (MiT) transcription factor with apilimod and related compositions and methods. 本公开内容涉及使用阿吡莫德在具有过度表达小眼(MiT)转录因子的癌细胞的受试者中治疗癌症的组合物和方法，以及相关的组合物和方法。...

Full description

Saved in:
Bibliographic Details
Main Authors BEEHARRY NEIL, LANDRETTE SEAN, CONRAD CHRIS, BECKETT PAUL, XU TIAN, LICHENSTEIN HENRI, HERNANDEZ MARYLENS, ROTHBERG JONATHAN M, GAYLE SOPHIA
Format Patent
LanguageChinese
English
Published 04.09.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to compositions and methods for treating cancer in a subject having cancer cells overexpressing a microphthalmia (MiT) transcription factor with apilimod and related compositions and methods. 本公开内容涉及使用阿吡莫德在具有过度表达小眼(MiT)转录因子的癌细胞的受试者中治疗癌症的组合物和方法，以及相关的组合物和方法。
Bibliography:Application Number: CN201780007526